The prognosis for gastrointestinal (GI) cancer depends on the type and stage of cancer at diagnosis. Early-stage GI cancers, including stomach, colon, and esophageal cancers, have better survival rates when treated with surgery, chemotherapy, or radiation. Advanced-stage cancers are more difficult to treat and often require palliative care.

A total gastrectomy is a surgical procedure where the entire stomach is removed, usually due to stomach cancer or severe damage. The esophagus is then directly connected to the small intestine. This life-altering surgery requires patients to follow strict dietary guidelines, including smaller, more frequent meals, and take supplements to ensure proper nutrition.

Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

Atrophic gastritis is a chronic condition where the stomach lining thins and loses its ability to produce stomach acid and digestive enzymes. This condition can be caused by long-term H. pylori infection or autoimmune diseases and may increase the risk of stomach cancer. Treatment focuses on addressing the underlying cause and managing symptoms.